Abstract
Panic disorder (PD) is an anxiety disorder characterized by recurrent panic attacks with a lifetime prevalence of 4.7%. Genetic factors are known to contribute to the development of the disorder. Several lines of evidence point towards a major role of the norepinephrine system in the pathogenesis of PD. The SLC6A2 gene is located on chromosome 16q12.2 and encodes the norepinephrine transporter (NET), responsible for the reuptake of norepinephrine into presynaptic nerve terminals. The aim of the present study was to analyze genetic variants located within the NET gene for association with PD. The case–control sample consisted of 449 patients with PD and 279 ethnically matched controls. All cases fulfilled the ICD-10 diagnostic criteria for PD. Genotyping was performed using the Sequenom platform (Sequenom, Inc, San Diego, USA). To test for allelic and haplotypic association, the PLINK software was used, and COMBASSOC was applied to test for gene-wise association. After quality control 29 single nucleotide polymorphisms (SNPs) spanning the gene-region were successfully analyzed. Seven SNPs located within the 5′ end of the gene were significantly associated with PD. Furthermore, the NET gene showed overall evidence for association with the disease (P = 0.000035). In conclusion, the present study indicates that NET could be a susceptibility gene for PD.
Similar content being viewed by others
References
Banaschewski T, Becker K, Scherag S, Franke B, Coghill D (2010) Molecular genetics of attention-deficit/hyperactivity disorder: an overview. Eur Child Adolesc Psychiatry 19(3):237–257
Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263–265
Bosker FJ, Hartman CA, Nolte IM, Prins BP, Terpstra P, Posthuma D, van VT, Willemsen G, Derijk RH, de Geus EJ, Hoogendijk WJ, Sullivan PF, Penninx BW, Boomsma DI, Snieder H, Nolen WA (2010) Poor replication of candidate genes for major depressive disorder using genome-wide association data. Mol Psychiatry [Epub ahead of print]
Bremner JD, Krystal JH, Southwick SM, Charney DS (1996) Noradrenergic mechanisms in stress and anxiety: II. Clinical studies. Synapse 23(1):39–51
Charney DS, Heninger GR, Breier A (1984) Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 41(8):751–763
Curtis D, Vine AE, Knight J (2008) A simple method for assessing the strength of evidence for association at the level of whole gene. Adv Appl Bioinformatics Chem 1:115–120
Dell’Osso B, Buoli M, Baldwin DS, Altamura AC (2010) Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: a comprehensive review of their clinical efficacy. Hum Psychopharmacol 25(1):17–29
Erhardt A, Czibere L, Roeske D, Lucae S, Unschuld PG, Ripke S, Specht M, Kohli MA, Kloiber S, Ising M, Heck A, Pfister H, Zimmermann P, Lieb R, Putz B, Uhr M, Weber P, Deussing JM, Gonik M, Bunck M, Kessler MS, Frank E, Hohoff C, Domschke K, Krakowitzky P, Maier W, Bandelow B, Jacob C, Deckert J, Schreiber S, Strohmaier J, Nothen M, Cichon S, Rietschel M, Bettecken T, Keck ME, Landgraf R, Muller-Myhsok B, Holsboer F, Binder EB (2010) TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Mol Psychiatry [Epub ahead of print]
Fajas L, Le CL, Polanowska J, Fabbrizio E, Servant N, Philips A, Carnac G, Sardet C (2000) A CDE/CHR-like element mediates repression of transcription of the mouse RB2 (p130) gene. FEBS Lett 471(1):29–33
Gordon D, Finch SJ, Nothnagel M, Ott J (2002) Power and sample size calculations for case–control genetic association tests when errors are present: application to single nucleotide polymorphisms. Hum Hered 54(1):22–33
Gordon D, Levenstien MA, Finch SJ, Ott J (2003) Errors and linkage disequilibrium interact multiplicatively when computing sample sizes for genetic case–control association studies. Pac Symp Biocomput 490–501
Hettema JM, Neale MC, Kendler KS (2001) A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 158(10):1568–1578
Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M, Blazer DG (1996) Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry Suppl (30) 17–30
Kessler RC, Stang PE, Wittchen HU, Ustun TB, Roy-Burne PP, Walters EE (1998) Lifetime panic-depression comorbidity in the National Comorbidity Survey. Arch Gen Psychiatry 55(9):801–808
Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE (2006) The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry 63(4):415–424
Kim TH, Abdullaev ZK, Smith AD, Ching KA, Loukinov DI, Green RD, Zhang MQ, Lobanenkov VV, Ren B (2007) Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome. Cell 128(6):1231–1245
Koefoed P, Woldbye DP, Hansen TO, Hansen ES, Knudsen GM, Bolwig TG, Rehfeld JF (2010) Gene variations in the cholecystokinin system in patients with panic disorder. Psychiatr Genet 20(2):59–64
Kolstad HA, Hansen AM, Kærgaard A, Thomsen JF, Kærlev L, Kristensen AS, Mors O, Mikkelsen S, Grynderup MB, Ruguiles R, Andersen JH, Bonde JP (2011) Job strain and the risk of depression: is reporting biased? Am J Epidemiol 173:94–102
Kristensen AS, Mortensen EL, Mors O (2008) Social phobia with sudden onset—post-panic social phobia? J Anxiety Disord 22(4):684–692
Lee YJ, Hohoff C, Domschke K, Sand P, Kuhlenbaumer G, Schirmacher A, Freitag CM, Meyer J, Stober G, Franke P, Nothen MM, Fritze J, Fimmers R, Garritsen HS, Stogbauer F, Deckert J (2005) Norepinephrine transporter (NET) promoter and 5’-UTR polymorphisms: association analysis in panic disorder. Neurosci Lett 377(1):40–43
Li Y, Willer C, Sanna S, Abecasis G (2009) Genotype imputation. Annu Rev Genomics Hum Genet 10:387–406
Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR (2010) MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 34:816–834
Novembre J, Johnson T, Bryc K, Kutalik Z, Boyko AR, Auton A, Indap A, King KS, Bergmann S, Nelson MR, Stephens M, Bustamante CD (2008) Genes mirror geography within Europe. Nature 456(7218):98–101
Otowa T, Yoshida E, Sugaya N, Yasuda S, Nishimura Y, Inoue K, Tochigi M, Umekage T, Miyagawa T, Nishida N, Tokunaga K, Tanii H, Sasaki T, Kaiya H, Okazaki Y (2009) Genome-wide association study of panic disorder in the Japanese population. J Hum Genet 54(2):122–126
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3):559–575
Quandt K, Frech K, Karas H, Wingender E, Werner T (1995) MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 23(23):4878–4884
Sand PG, Mori T, Godau C, Stober G, Flachenecker P, Franke P, Nothen MM, Fritze J, Maier W, Lesch KP, Riederer P, Beckmann H, Deckert J (2002) Norepinephrine transporter gene (NET) variants in patients with panic disorder. Neurosci Lett 333(1):41–44
Torres GE, Gainetdinov RR, Caron MG (2003) Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci 4(1):13–25
Uher R, Huezo-Diaz P, Perroud N, Smith R, Rietschel M, Mors O, Hauser J, Maier W, Kozel D, Henigsberg N, Barreto M, Placentino A, Dernovsek MZ, Schulze TG, Kalember P, Zobel A, Czerski PM, Larsen ER, Souery D, Giovannini C, Gray JM, Lewis CM, Farmer A, Aitchison KJ, McGuffin P, Craig I (2009) Genetic predictors of response to antidepressants in the GENDEP project. Pharmacogenomics J 9(4):225–233
Uher R, Perroud N, Ng MY, Hauser J, Henigsberg N, Maier W, Mors O, Placentino A, Rietschel M, Souery D, Zagar T, Czerski PM, Jerman B, Larsen ER, Schulze TG, Zobel A, Cohen-Woods S, Pirlo K, Butler AW, Muglia P, Barnes MR, Lathrop M, Farmer A, Breen G, Aitchison KJ, Craig I, Lewis CM, McGuffin P (2010) Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. Am J Psychiatry 167(5):555–564
Versiani M, Cassano G, Perugi G, Benedetti A, Mastalli L, Nardi A, Savino M (2002) Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder. J Clin Psychiatry 63(1):31–37
Werner T (2000) Computer-assisted analysis of transcription control regions. Mat inspector and other programs. Methods Mol Biol 132:337–349
World Health Organization (1993) The ICD-10 classification of mental and behavioural disorders, diagnostic criteria for research
World Health Organization (1998) Diagnosis and clinical measurement in psychiatry. A reference manual for SCAN
Acknowledgments
The authors acknowledge Karina Birk Nygaard, Tracey Flint and Mia Boe Oddershede for excellent technical assistance. The study was supported by the Lundbeck foundation, “TRYG fonden”, “Forskningsfonden til støtte af psykiatrisk forskning i Region Midtjylland”, “Toyota fonden”, Denmark, and the Villum Kann Rasmussen Foundation.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Buttenschøn, H.N., Kristensen, A.S., Buch, H.N. et al. The norepinephrine transporter gene is a candidate gene for panic disorder. J Neural Transm 118, 969–976 (2011). https://doi.org/10.1007/s00702-011-0624-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-011-0624-7